【2176】イナリサーチ〔上場廃止〕

ー(上場廃止)医薬品の非臨床試験。

東証スタンダード

サービス業サー

＞

CRO、SMO 治験

業績予想修正履歴

{{models[key].tabname}}

決算期	日付	予・実	売上高 (百万円)	対前回	修正率	修正率	営業利益 (百万円)	対前回	修正率	修正率	経常利益 (百万円)	対前回	修正率	修正率	当期利益 (百万円)	対前回	修正率	修正率
2023.03	2022/08/10	Q1予	4,328	→	0.0%	0.0%	373	→	0.0%	0.0%	350	→	0.0%	0.0%	298	→	0.0%	0.0%
2023.03	2022/05/12	当初予	4,328	-	-	-	373	-	-	-	350	-	-	-	298	-	-	-
2022.03	2022/05/12	実	3,204	→	0.0%	+0.1%	351	↑	+43.3%	+132.5%	339	↑	+0.6%	+173.4%	334	↓	-1.5%	+215.1%
2022.03	2022/04/15	修正予	3,204	↓	-2.3%	+0.1%	-	-	-	-	337	↑	+47.8%	+171.8%	339	↑	+77.5%	+219.8%
2022.03	2022/02/10	Q3予	3,278	→	0.0%	+2.4%	245	↑	+7.5%	+62.3%	228	→	0.0%	+83.9%	191	→	0.0%	+80.2%
2022.03	2022/01/27	修正予	3,278	→	0.0%	+2.4%	-	-	-	-	228	↑	+16.9%	+83.9%	191	↑	+19.4%	+80.2%
2022.03	2021/11/11	Q2予	3,278	→	0.0%	+2.4%	228	→	0.0%	+51.0%	195	→	0.0%	+57.3%	160	→	0.0%	+50.9%
2022.03	2021/10/27	修正予	3,278	↑	+2.4%	+2.4%	228	↑	+51.0%	+51.0%	195	↑	+57.3%	+57.3%	160	↑	+50.9%	+50.9%
2022.03	2021/08/05	Q1予	3,200	→	0.0%	0.0%	151	→	0.0%	0.0%	124	→	0.0%	0.0%	106	→	0.0%	0.0%
2022.03	2021/05/13	当初予	3,200	-	-	-	151	-	-	-	124	-	-	-	106	-	-	-
2021.03	2021/05/13	実	2,929	→	0.0%	-9.9%	205	↑	+169.7%	+169.7%	177	→	0.0%	+268.8%	232	→	0.0%	+510.5%
2021.03	2021/05/10	修正予	2,929	↓	-9.9%	-9.9%	-	-	-	-	177	↑	+268.8%	+268.8%	232	↑	+510.5%	+510.5%
2021.03	2021/02/10	Q3予	3,250	→	0.0%	0.0%	76	→	0.0%	0.0%	48	→	0.0%	0.0%	38	→	0.0%	0.0%
2021.03	2020/11/06	Q2予	3,250	→	0.0%	0.0%	76	→	0.0%	0.0%	48	→	0.0%	0.0%	38	→	0.0%	0.0%
2021.03	2020/08/06	Q1予	3,250	→	0.0%	0.0%	76	→	0.0%	0.0%	48	→	0.0%	0.0%	38	→	0.0%	0.0%
2021.03	2020/05/13	当初予	3,250	-	-	-	76	-	-	-	48	-	-	-	38	-	-	-
2020.03	2020/05/13	実	2,862	↓	-4.5%	-4.5%	61	↓	-41.3%	-41.3%	30	↓	-60.0%	-60.0%	36	↓	-42.9%	-42.9%
2020.03	2020/02/13	Q3予	2,996	→	0.0%	0.0%	104	→	0.0%	0.0%	75	→	0.0%	0.0%	63	→	0.0%	0.0%
2020.03	2019/11/13	Q2予	2,996	→	0.0%	0.0%	104	→	0.0%	0.0%	75	→	0.0%	0.0%	63	→	0.0%	0.0%
2020.03	2019/08/09	Q1予	2,996	→	0.0%	0.0%	104	→	0.0%	0.0%	75	→	0.0%	0.0%	63	→	0.0%	0.0%
2020.03	2019/05/14	当初予	2,996	-	-	-	104	-	-	-	75	-	-	-	63	-	-	-
2019.03	2019/05/14	実	2,585	↓	-6.9%	-6.9%	93	↓	-21.2%	-20.5%	60	↓	-24.1%	-23.1%	56	↓	-16.4%	-15.2%
2019.03	2019/02/13	Q3予	2,778	→	0.0%	0.0%	118	→	0.0%	+0.9%	79	→	0.0%	+1.3%	67	→	0.0%	+1.5%
2019.03	2018/11/12	Q2予	2,778	→	0.0%	0.0%	118	→	0.0%	+0.9%	79	→	0.0%	+1.3%	67	→	0.0%	+1.5%
2019.03	2018/08/10	Q1予	2,778	→	0.0%	0.0%	118	↑	+0.9%	+0.9%	79	↑	+1.3%	+1.3%	67	↑	+1.5%	+1.5%
2019.03	2018/05/14	当初予	2,778	-	-	-	117	-	-	-	78	-	-	-	66	-	-	-
2018.03	2018/05/14	実	2,425	↑	+5.4%	+5.4%	196	↑	+148.1%	+148.1%	156	↑	+1460.0%	+1460.0%	141	↑	+2250.0%	+2250.0%
2018.03	2018/02/13	Q3予	2,300	→	0.0%	0.0%	79	→	0.0%	0.0%	10	→	0.0%	0.0%	6	→	0.0%	0.0%
2018.03	2017/11/13	Q2予	2,300	→	0.0%	0.0%	79	→	0.0%	0.0%	10	→	0.0%	0.0%	6	→	0.0%	0.0%
2018.03	2017/08/10	Q1予	2,300	-	-	-	79	-	-	-	10	-	-	-	6	-	-	-
2017.12	2017/05/12	当初予	2,295	-	-	-	56	-	-	-	23	-	-	-	31	-	-	-
2017.03	2017/05/12	実	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2017.03	2017/02/14	Q3予	2,342	→	0.0%	0.0%	47	→	0.0%	0.0%	9	→	0.0%	0.0%	0	→	-	-
2017.03	2016/11/14	Q2予	2,342	→	0.0%	0.0%	47	→	0.0%	0.0%	9	→	0.0%	0.0%	0	→	-	-
2017.03	2016/08/12	Q1予	2,342	-	-	-	47	-	-	-	9	-	-	-	0	-	-	-
2016.12	2016/05/13	当初予	2,116	-	-	-	-207	-	-	-	-230	-	-	-	-1,204	-	-	-
2016.03	2016/05/13	実	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2016.03	2016/02/12	Q3予	2,110	→	0.0%	-5.4%	-334	→	0.0%	-895.2%	-357	→	0.0%	-2846.2%	-765	→	0.0%	-11028.6%
2016.03	2015/11/13	Q2予	2,110	→	0.0%	-5.4%	-334	→	0.0%	-895.2%	-357	→	0.0%	-2846.2%	-765	→	0.0%	-11028.6%
2016.03	2015/11/02	修正予	2,110	↓	-5.4%	-5.4%	-334	↓	-895.2%	-895.2%	-357	↓	-2846.2%	-2846.2%	-765	↓	-11028.6%	-11028.6%
2016.03	2015/08/14	Q1予	2,230	→	0.0%	0.0%	42	-	-	-	13	→	0.0%	0.0%	7	→	0.0%	0.0%
2016.03	2015/05/15	当初予	2,230	-	-	-	-	-	-	-	13	-	-	-	7	-	-	-
2015.03	2015/05/15	実	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2015.03	2015/02/10	Q3予	3,000	→	0.0%	0.0%	83	→	0.0%	0.0%	50	→	0.0%	0.0%	28	→	0.0%	0.0%
2015.03	2014/11/11	Q2予	3,000	→	0.0%	0.0%	83	→	0.0%	0.0%	50	→	0.0%	0.0%	28	→	0.0%	0.0%
2015.03	2014/08/12	Q1予	3,000	→	0.0%	0.0%	83	→	0.0%	0.0%	50	→	0.0%	0.0%	28	→	0.0%	0.0%
2015.03	2014/05/13	当初予	3,000	-	-	-	83	-	-	-	50	-	-	-	28	-	-	-
2014.03	2014/05/13	実	2,778	→	0.0%	0.0%	66	→	0.0%	0.0%	49	→	0.0%	0.0%	70	→	0.0%	0.0%
2014.03	2014/05/07	当初予	2,778	-	-	-	66	-	-	-	49	-	-	-	70	-	-	-

【2176】イナリサーチ 〔上場廃止〕 ー(上場廃止)医薬品の非臨床試験。

業績予想修正履歴

【2176】イナリサーチ〔上場廃止〕

ー(上場廃止)医薬品の非臨床試験。